Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does RIVAROXABAN Cause Tricuspid valve incompetence? 128 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 128 reports of Tricuspid valve incompetence have been filed in association with RIVAROXABAN (Rivaroxaban). This represents 0.1% of all adverse event reports for RIVAROXABAN.

128
Reports of Tricuspid valve incompetence with RIVAROXABAN
0.1%
of all RIVAROXABAN reports
2
Deaths
40
Hospitalizations

How Dangerous Is Tricuspid valve incompetence From RIVAROXABAN?

Of the 128 reports, 2 (1.6%) resulted in death, 40 (31.3%) required hospitalization, and 2 (1.6%) were considered life-threatening.

Is Tricuspid valve incompetence Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for RIVAROXABAN. However, 128 reports have been filed with the FAERS database.

What Other Side Effects Does RIVAROXABAN Cause?

Gastrointestinal haemorrhage (20,041) Haemorrhage (6,571) Epistaxis (5,629) Rectal haemorrhage (4,501) Off label use (4,463) Haematuria (4,387) Upper gastrointestinal haemorrhage (4,247) Cerebrovascular accident (4,111) Anaemia (3,907) Acute kidney injury (3,735)

What Other Drugs Cause Tricuspid valve incompetence?

FENFLURAMINE (454) PANTOPRAZOLE (219) SACUBITRIL\VALSARTAN (218) BISOPROLOL (212) ASPIRIN (188) FUROSEMIDE (186) ONDANSETRON (168) DICLOFENAC (152) CLOZAPINE (141) VALSARTAN (140)

Which RIVAROXABAN Alternatives Have Lower Tricuspid valve incompetence Risk?

RIVAROXABAN vs RIVASTIGMINE RIVAROXABAN vs RIVOTRIL RIVAROXABAN vs RIZATRIPTAN RIVAROXABAN vs ROACTEMRA RIVAROXABAN vs ROCURONIUM

Related Pages

RIVAROXABAN Full Profile All Tricuspid valve incompetence Reports All Drugs Causing Tricuspid valve incompetence RIVAROXABAN Demographics